Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
“In serious human infections, rapidity of antimicrobial therapy following presentation has been understood to be a critical determinant of outcome for specific conditions including community-acquired pneumonia (7, 9, 14, 17), ventilator-associated pneumonia (11), meningitis (10, 13), bacteremia (14, 15), and septic sho…”
BackgroundSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
“[46] found that, compared with prompt treatment, delayed treatment was an independent predictor of infection-related mortality (mortality rate, 33.”
Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., et al. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa036 · Cited by 1,202
Self-citationEfflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502522 · Cited by 856
Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2008) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767
“For the present study, we decided to analyze the impact of empirical antibiotic treatment on mortality, because there is a large amount of evidence to support the importance of early antibiotic administration [1, 29, 30].”
BackgroundChallenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
Antimicrobial Stewardship Programs in Health Care Systems
MacDougall, C., & Polk, R. E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.638-656.2005 · Cited by 705
“Inappropriate or delayed empirical antimicrobial therapy has been associated with increased mortality in a number of recent studies (76, 84, 93, 95, 98, 99).”
BackgroundHassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
“SAB lead to poorer clinical outcomes [18].”
Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
“cells/mm), (iii) with an MRSA culture that met the CDC criteria for bloodstream infection (4), (iv) had received vancomycin therapy within 48 h of the index blood culture collection (10), and (v) had survived 24 h after vancomycin adminis-”
BackgroundSelf-citationMicek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
“These investigations support the importance of early administration of appropriate antibiotics to patients with serious infections, including bloodstream infection (22).”
BackgroundHuang, A. M., Newton, D., Kunapuli, A., Gandhi, T. N., Washer, L. L., Isip, J., Collins, C. D., & Nagel, J. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit498 · Cited by 510
Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis
Saby, L., Laas, O., Habib, G., Cammilleri, S., Mancini, J., Tessonnier, L., Casalta, J.-P., Gouriet, F., Riberi, A., Avierinos, J.-F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.092 · Cited by 503
“The early diagnosis of endocarditis is of crucial importance because a delay in antibiotic therapy and cardiac surgery has negative effects on clinical outcomes (3,25).”
BackgroundGemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
“Other factors including acute physiological score have been shown to be important in predicting mortality in bacteraemia overall.(69,71) Good control of diabetes mellitus, drainage of abscesses and particularly removal of sources such as intravenous (iv) lines,(72) are important in predicting outcome.”
BackgroundManagement of infective endocarditis: challenges and perspectives
Thuny, F., Grisoli, D., Collart, F., Habib, G., & Raoult, D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60755-1 · Cited by 437
The Era of Molecular and Other Non-Culture-Based Methods in Diagnosis of Sepsis
Mancini, N., Carletti, S., Ghidoli, N., Cichero, P., Burioni, R., & Clementi, M. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-09 · Cited by 407
“This aspect is important, as several studies have shown that inadequate antimicrobial therapy is an independent risk factor for mortality or microbiological failure for severely ill patients with life-threatening infections (81, 100, 102, 105, 206, 217).”
BackgroundPerez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Land, G. A., Peterson, L. E., & Musser, J. M. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0651-oa · Cited by 388
Bauer, K. A., West, J. E., Balada‐Llasat, J., Pancholi, P., Stevenson, K. B., & Goff, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/656623 · Cited by 347
“infection-related mortality and longer hospital stay [16].”
Clinical and economic burden of antimicrobial resistance
Maragakis, L. L., Perencevich, E. N., & Cosgrove, S. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.751 · Cited by 329
“Similarly, a recent systematic review and meta-analysis by Schwaber and Carmeli examined 16 studies using a random-effects model and found that ESBL production is associated with increased mortality and delay in effective antimicrobial therapy for patients with Enterobacteriaceae bacteremia [99].”
BackgroundInfluentialLodise, T. P., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., & McGregor, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-07 · Cited by 318
“aeruginosa blood culture and the administration of appropriate antibiotic treatment and to identify the temporal breakpoint that maximized the difference in 30-day mortality, thereby dividing the study population into two groups: those with a high likelihood of 30-day mortality (delayed treatment) and those with a low…”
BackgroundResultSelf-citationStaphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies
Naber, C. K. (2009) · Clinical Infectious Diseases · doi:10.1086/598189 · Cited by 313
“Empirical therapy is of critical importance in the treatment of SAB, because delaying antibiotic treatment, even by only 45 h, has been shown to increase the risk of infection-related mortality and to increase the duration of hospitalization [53].”
BackgroundChristner, M., Rohde, H., Wolters, M., Sobottka, I., Wegscheider, K., & Aepfelbacher, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01831-09 · Cited by 303
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database*
Shorr, A. F., Tabak, Y. P., Killian, A. D., Gupta, V., Liu, L. Z., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239121.09533.09 · Cited by 286
Bundled care for septic shock: An analysis of clinical trials*
Barochia, A. V., Cui, X., Vitberg, D., Suffredini, A. F., OʼGrady, N. P., Banks, S. M., Minneci, P., Kern, S. J., Danner, R. L., Natanson, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0ddf · Cited by 279
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
“associated with MRSA infection [23].”
The GRADE system for rating clinical guidelines
Kavanagh, B. P. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000094 · Cited by 246
“Three studies published between 2004 and 2008 (none of them randomized controlled trials) supported the idea that early antibiotics reduced mortality in sepsis [45–47], exactly the same conclusions reached by at least six others published before 2004 [48–53].”
ResultCommunity‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections
Oved, K., Cohen, A., Boico, O., Navon, R., Friedman, T., Etshtein, L., Kriger, O., Bamberger, E., Fonar, Y., Yacobov, R., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120012 · Cited by 239
Shurland, S., Zhan, M., Bradham, D. D., & Roghmann, M.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/512627 · Cited by 236
Lopez-Cortes, L. E., del Toro, M. D., Galvez-Acebal, J., Bereciartua-Bastarrica, E., Farinas, M. C., Sanz-Franco, M., Natera, C., Corzo, J. E., Lomas, J. M., Pasquau, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit499 · Cited by 231
“than catheter-related, central nervous system infections, intraabdominal infections, and respiratory tract infections [21, 22].”
Vogel, M., Schmitz, R. P. H., Hagel, S., Pletz, M. W., Gagelmann, N., Scherag, A., Schlattmann, P., & Brunkhorst, F. M. (2016) · Journal of Infection · doi:10.1016/j.jinf.2015.09.037 · Cited by 227
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
Noskin, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/431672 · Cited by 226
“The initial choice for empirical therapy is crucial, and, if the choice is inappropriate, it may have adverse consequences for the patient [1, 2 ]. Changing patterns of antimicrobial resistance among bacteria that commonly cause serious infections present difficult challenges for clinicians, often necessitating the us…”
McDanel, J. S., Perencevich, E. N., Diekema, D. J., Herwaldt, L. A., Smith, T. C., Chrischilles, E. A., Dawson, J. D., Jiang, L., Goto, M., & Schweizer, M. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ308 · Cited by 225
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O'Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Warren, S. J. C., Gao, W., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-12 · Cited by 224
“Attributable 30-day mortality was also evaluated using previously published criteria (24).”
MethodMoore, C. L., Osaki-Kiyan, P., Haque, N. Z., Perri, M. B., Donabedian, S., & Zervos, M. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir764 · Cited by 220
Ljungström, L., Pernestig, A.-K., Jacobsson, G., Andersson, R., Usener, B., & Tilevik, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181704 · Cited by 219
Pliakos, E. E., Andreatos, N., Shehadeh, F., Ziakas, P. D., & Mylonakis, E. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00095-17 · Cited by 216
Hanberger, H., Walther, S., Léone, M., Barie, P. S., Rello, J., Lipman, J., Marshall, J. C., Anzueto, A., Sakr, Y. L., Pickkers, P., et al. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.013 · Cited by 215
“Increased MICs to vancomycin [20–22], delay in appropriate antimicrobial therapy [23–28], inferior bactericidal effect of vancomycin and suboptimal antibiotic dosage [29] are factors and mechanisms that may be involved in the increased mortality associated with MRSA infections, but we were unable to assess these.”
BackgroundMarquet, K., Liesenborgs, A., Bergs, J., Vleugels, A., & Claes, N. (2015) · Critical Care · doi:10.1186/s13054-015-0795-y · Cited by 203
“75 hours, and delayed treatment was found to be an independent predictor of infection-related mortality [68].”
BackgroundToward Resolving the Challenges of Sepsis Diagnosis
Carrigan, S. D., Scott, G., & Tabrizian, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032144 · Cited by 200
“For studies requiring that treatment begin within 48 h of pathogen isolation, inappropriate treatment is reported in 27–29% of cases (3, 4).”
BackgroundKuti, E. L., Patel, A. A., & Coleman, C. I. (2008) · Journal of Critical Care · doi:10.1016/j.jcrc.2007.08.007 · Cited by 199
“Our literature search identified 109 potential studies, 32 of which fulfilled our selection criteria [6-23,25-38].”
BackgroundMethodResultInfluentialLodise, T. P., & McKinnon, P. S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.007 · Cited by 199
Self-citationDavis, S. L., Perri, M. B., Donabedian, S. M., Manierski, C., Singh, A., Vager, D., Haque, N. Z., Speirs, K., Muder, R. R., Robinson-Dunn, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02311-06 · Cited by 196
“Death was considered attributable to S. aureus infection if at least one of the following criteria were present: (i) cultures were positive for S. aureus at the time of death, (ii) death occurred before the resolution of the signs and symptoms of S. aureus infection, or (iii) death occurred within 2 weeks of the onset…”
BackgroundMcGregor, J. C., Rich, S. E., Harris, A. D., Perencevich, E. N., Osih, R., Lodise, T. P., Miller, R. R., & Furuno, J. P. (2007) · Clinical Infectious Diseases · doi:10.1086/519283 · Cited by 194
“Only 2 publications assessed the time to appropriate therapy as a risk factor for mortality [10, 41].”
BackgroundSelf-citationHyle, E. P., Lipworth, A. D., Zaoutis, T. E., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1375 · Cited by 194
Meticillin-resistant Staphylococcus aureus
Boyce, J. M., Cookson, B., Christiansen, K., Hori, S., Vuopio-Varkila, J., Kocagöz, S., Öztop, A. Y., Vandenbroucke-Grauls, C. M., Harbarth, S., & Pittet, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70243-7 · Cited by 187
“[2] [3] [4] [5] [6] [7] In some facilities, the proportion of health-care-associated S aureus infections caused by MRSA is even higher.”
Mohr, J. F., & Murray, B. E. (2007) · Clinical Infectious Diseases · doi:10.1086/518451 · Cited by 185
“On the basis of the increase in hVISA associated with initial low vancomycin concentrations [10], various in vitro observations associated with the emergence of hVISA with low vancomycin exposures [13], reports of clinical failures with hVISA [12], and the improved outcomes associated with early empirical [28] plus ag…”
BackgroundFerreira, L., Sánchez-Juanes, F., Porras-Guerra, I., García-García, M. I., García-Sánchez, J. E., González-Buitrago, J. M., & Muñoz-Bellido, J. L. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03257.x · Cited by 182
“Some studies [17,18] suggest that mortality is 70% lower in patients receiving appropriate empirical treatment.”
BackgroundSeifert, H. (2009) · Clinical Infectious Diseases · doi:10.1086/598188 · Cited by 177
Kaech, C., Elzi, L., Sendi, P., Frei, R., Laifer, G., Bassetti, S., & Flückiger, U. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01359.x · Cited by 174
Gould, F. K., Brindle, R., Chadwick, P. R., Fraise, A. P., Hill, S., Nathwani, D., Ridgway, G. L., Spry, M. J., Warren, R. E., & on behalf of the MRSA Working Party of the British Society for Antimicrobial Chemotherapy (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp065 · Cited by 155
“We referred in previous guidance to two studies showing that a relatively short period of up to 48 h delay in switching from b-lactam antibiotics to appropriate therapy for non-severe methicillin-resistant infections does not affect outcome.(80,81) Previous guidance of a step-down approach to severe S.”
ResultPersistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome
Khatib, R., Johnson, L. B., Fakih, M. G., Riederer, K., Khosrovaneh, A., Shamse Tabriz, M., Sharma, M., & Saeed, S. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500372846 · Cited by 168
Lodise, T. P., Drusano, G. L., Zasowski, E., Dihmess, A., Lazariu, V., Cosler, L., & McNutt, L.-A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu398 · Cited by 167
“Additional data elements included source of MRSA BSI, mortality risk associated with infection source [24, 28, 29], presence of infective endocarditis [30], infection source control intervention, microbiologic data, treatment data, occurrence of nephrotoxicity (defined as either a 50% or 0.”
BackgroundMethodInfluentialSelf-citationStaphylococcus aureusbacteraemia and endocarditis – epidemiology and outcome: a review
Ásgeirsson, H., Thalme, A., & Weiland, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1392039 · Cited by 163
Sepsis and septic shock: Pathogenesis and treatment perspectives
Minasyan, H. A. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.04.015 · Cited by 162
“This results in diagnostic uncertainty, therapeutic delays, the mis- and overuse of antibiotics and many other problems that increase mortality [128-131].”
BackgroundThe clinical significance of methicillin-resistant Staphylococcus aureus
Gould, I. M. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.06.014 · Cited by 159
Appropriate vs. inappropriate antimicrobial therapy
Davey, P. G., & Marwick, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01959.x · Cited by 158
“reported in the literature vary widely among studies [3,4,6,7] (Table 1).”
Community‐Associated Methicillin‐Resistant Staphylococcus aureus: A Review
Rybak, M. J., & LaPlante, K. L. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.1.74.55620 · Cited by 128
Self-citationKhatib, R., Saeed, S., Sharma, M., Riederer, K., Fakih, M. G., & Johnson, L. B. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0096-0 · Cited by 156
“timing of antibiotics was addressed in only a few studies with conflicting results [4, 5, 7].”
BackgroundResultInfluentialHealthcare Epidemiology: Does Antibiotic Selection Impact Patient Outcome?
Harbarth, S., Junior, V. A. N., & Pittet, D. (2006) · Clinical Infectious Diseases · doi:10.1086/510075 · Cited by 144
Renal Dosing of Antibiotics: Are We Jumping the Gun?
Crass, R. L., Rodvold, K. A., Mueller, B. A., & Pai, M. P. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy790 · Cited by 141
Zasowski, E. J., Claeys, K. C., Lagnf, A. M., Davis, S. L., & Rybak, M. J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw110 · Cited by 134
“aureus and Pseudomonas aeruginosa BSI of approximately 48 hours, after which the risk of mortality was increased [32, 33].”
BackgroundSelf-citationSaravolatz, L. D., Pea, F., & Viale, P. (2006) · Clinical Infectious Diseases · doi:10.1086/504383 · Cited by 137
Forsblom, E., Ruotsalainen, E., Ollgren, J., & Järvinen, A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis889 · Cited by 125
“SAB outcome is worse if proper antibiotic therapy is delayed [21].”
Orvin, K., Goldberg, E., Bernstine, H., Groshar, D., Sagie, A., Kornowski, R., & Bishara, J. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.08.012 · Cited by 134
“Early diagnosis of ECC has important therapeutic implications [27–29] but may be extremely challenging because of the lack of characteristic symptoms and the need for several imaging modalities to perform a comprehensive evaluation [5].”
BackgroundWallet, F., Nseir, S., Baumann, L., Herwegh, S., Sendid, B., Boulo, M., Roussel‐Delvallez, M., Durocher, A.-M., & Courcol, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02940.x · Cited by 133
“For instance, rapid and substantiated management of sepsis is recommended for infections due to Pseudomonas aeruginosa [4] and Staphylococcus aureus [5].”
BackgroundEpidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America
Guzmán-Blanco, M., Mejía, C., Istúriz, R., Álvarez, C., Luis Bavestrello, F., Gotuzzo, E., Labarca, J. A., Luna, C. M., Rodríguez-Noriega, E., Salles, M. J. C., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.005 · Cited by 133
The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis
Zhang, X., Liu, D., Liu, Y.-N., Wang, R., & Xie, L. (2015) · Critical Care · doi:10.1186/s13054-015-1032-4 · Cited by 132
“Delays in the initiation of antimicrobial treatment are associated with worse prognosis [4, 5], which highlights the importance of timely diagnosis to reduce the morbidity and mortality of sepsis patients.”
BackgroundProportion of Surgical Site Infections Occurring after Hospital Discharge: A Systematic Review
Woelber, E., Schrick, E. J., Gessner, B. D., & Evans, H. L. (2016) · Surgical Infections · doi:10.1089/sur.2015.241 · Cited by 129
“This substantially increased risk of infection-related death also was accompanied by a longer hospital stay after bacteremia [75].”
InfluentialPolicies and Incentives for Promoting Innovation in Antibiotic Research
Mossialos, E. A., Morel, C. M., Edwards, S., Berenson, J. A., Gemmill-Toyama, M., & Brogan, D. M. (2010) · Cited by 127
Yaw, L. K., Robinson, J. O., & Ho, K. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70876-x · Cited by 128
Bassetti, M., Trecarichi, E. M., Mesini, A., Spanu, T., Giacobbe, D. R., Rossi, M., Schenone, E., PASCALE, G. D., Molinari, M. P., Cauda, R., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03679.x · Cited by 127
“The impact of appropriate empirical therapy against MRSA on survival has been explored in several studies including only patients with bacteraemia; their results were contradictory [23,24].”
ResultProcalcitonin as a prognostic and diagnostic tool for septic complications after major trauma*
Castelli, G. P., Pognani, C., Cita, M., & Paladini, R. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ffd5b · Cited by 108
Vos, F. J., Kullberg, B. J., Sturm, P., Krabbe, P. F. M., van Dijk, A. P. J., Wanten, G. J. A., Oyen, W. J. G., & Bleeker‐Rovers, C. P. (2012) · Medicine · doi:10.1097/md.0b013e31824d7ed2 · Cited by 123
“Treatment delay and community acquisition (which is probably a surrogate marker of delayed treatment) are the most important risk factors for the development of metastatic infection.(9,10,24) Persistently positive blood cultures and fever despite appropriate antibiotic treatment have a predictive value for the presenc…”
BackgroundResultClinical implications of antimicrobial resistance for therapy
MacGowan, A. P., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn357 · Cited by 122
“In an effort to identify the delay in appropriate therapy associated with adverse outcomes, Lodise et al.47 used CART (Classification and Regression Tree) analysis to identify the delay in therapy associated with increased risk of 30 day mortality.”
MethodGherardi, G., Angeletti, S., Panitti, M., Pompilio, A., Bonaventura, G. D., Crea, F., Avola, A., Fico, L., Palazzo, C., Sapia, G. F., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.09.015 · Cited by 120
“015 with specific microorganisms (Anderson et al., 2006; Lodise et al., 2003; Micek et al., 2005; Morrell et al., 2005), those with bacteraemias associated with antibiotic-resistant bacteria (Kang et al.”
BackgroundLin, M. Y., Weinstein, R. A., & Hota, B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01553-07 · Cited by 112
“While several studies have shown an association between inappropriate antimicrobial therapy and mortality (1, 19, 23, 25, 27, 33, 36), other studies have not found a significant association (3, 5, 8, 20, 21, 29, 32, 38).”
BackgroundConventional and molecular techniques for the early diagnosis of bacteraemia
Paolucci, M., Landini, M. P., & Sambri, V. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.010 · Cited by 118
“[18] Lodise TP, McKinnon PS, Swiderski L, RybakMJ.”
ResultAntibiotic pharmacokinetic and pharmacodynamic considerations in critical illness
Mehrotra, R., Gaudio, R. D., & Palazzo, M. G. A. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2428-9 · Cited by 117
“More recent intensive care studies have re-emphasised the importance and impact on hospital mortality of both early administration and appropriate antibiotic use, where appropriateness was based on in vitro sensitivities [3, 4, 5].”
BackgroundJoint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections
Hazards, E. P. O. B. (2009) · EFSA Journal · doi:10.2903/j.efsa.2009.1372 · Cited by 116
Blot, S. I., Depuydt, P. O., Vogelaers, D., Decruyenaere, J. M. A., Waele, J. J. D., Hoste, E. A. J., Peleman, R. A., Claeys, G., Verschraegen, G., COLARDYN, F. A., et al. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502575 · Cited by 115
“The critical time interval between onset of bacteremia and initiation of adequate antibiotic therapy is considered to be 48 hours.(11) For infections caused by antibiotic-resistant pathogens, appropriate therapy is often delayed for more than 48 hours, which has been associated with a worse clinical outcome.”
BackgroundPaschke, A. A., Zaoutis, T., Conway, P. H., Xie, D., & Keren, R. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1527 · Cited by 115
“Age, y 1 88 (17) 1–4 327 (61) 5 118 (22) Female gender 491 (92) Race White 318 (60) Black 161 (30) Asian/Pacific Islander 12 (2) Other 42 (8) Hispanic ethnicity 13 (2) Child care attendance documented None 503 (94) Within 12 mo of UTI 25 (5) Within 18 mo of UTI 30 (6) Hospitalization None 520 (98) Within 30 d of UTI 5…”
Lodise, T. P., McKinnon, P. S., Levine, D. P., & Rybak, M. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-07 · Cited by 109
“The study included only those patients who met the following criteria: (i) positive MSSA bloodstream infection, (ii) MSSA bloodstream infection satisfying the modified Duke criteria for IE (13), (iii) documented recent use of intravenous drugs prior to admission in the medical record, and (iv) empirical treatment with…”
Self-citationAmmerlaan, H., Seifert, H., Harbarth, S., Brun‐Buisson, C., Torres, A., Antonelli, M. M., Kluytmans, J. A. J. W., Bonten, M. J. M., & Study on European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group (2009) · Clinical Infectious Diseases · doi:10.1086/605555 · Cited by 112
“The consequences of inadequate therapy include longer hospital stay, higher health care–associated costs, and even higher mortality rates [15–19], although this last association has not been found in some recent studies [20–22].”
BackgroundResultEpidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia
DeRyke, C. A., Lodise, T. P., Rybak, M. J., & McKinnon, P. S. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1414 · Cited by 112
Self-citationItani, K. M. F., Weigelt, J. A., Li, J. Z., & Duttagupta, S. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.09.003 · Cited by 111
Rapid separation of bacteria from blood—review and outlook
Pitt, W. G., Alizadeh, M., Husseini, G. A., McClellan, D. S., Buchanan, C. M., Bledsoe, C. G., Robison, R. A., Blanco, R., Roeder, B. L., Melville, M., et al. (2016) · Biotechnology Progress · doi:10.1002/btpr.2299 · Cited by 111
Blood cultures: key elements for best practices and future directions
Riedel, S. F., & Carroll, K. C. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0069-1 · Cited by 110
“independent risk factor for mortality in critically ill patients [8–11].”
Grim, S. A., Rapp, R. P., Martin, C. A., & Evans, M. E. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.2.253.56956 · Cited by 94
“0).(17) Equally concerning is the worldwide development of isolates exhibiting heteroresistance to vancomycin and the isolation of three strains of S.”
Backgroundde Guadiana‐Romualdo, L. G., Esteban-Torrella, P., González, M. V., Sánchez, R. J., Hernando‐Holgado, A., Ortín, A., Acebes, S. R., & Otón, M. D. A. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.02.011 · Cited by 106
Robinson, J. O., Langhi, S., Phillips, M. R., Pearson, J. C., Christiansen, K., Coombs, G. W., & Murray, R. J. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1585-y · Cited by 106
Kumar, A. (2014) · Virulence · doi:10.4161/viru.26913 · Cited by 86
“Additional retrospective studies of human bacteremia, candidemia, septic shock, community-acquired pneumonia, hospital-acquired pneumonia, surgical infections, meningitis with sepsis, and sepsis in solid organ transplants have confirmed that the mortality in these septic conditions is increased with significant delays…”
BackgroundBurden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes
Lodise, T. P., & McKinnon, P. S. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1001 · Cited by 105
“These patient factors may independently contribute to adverse clinical outcomes and obviate assessments of the relationship between methicillin resistance and patient outcome; indeed, this relationship has been studied extensively with varying conclusions.8, 10, 11, 13–15, 17, 18, 20, 21, 23, 24, 54–59 To clarify the…”
BackgroundInfluentialSelf-citationJorgensen, S. C. J., Zasowski, E. J., Trinh, T. D., Lagnf, A. M., Bhatia, S., Sabagha, N., Abdul‐Mutakabbir, J. C., Alosaimy, S., Mynatt, R. P., Davis, S. L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz746 · Cited by 105
Self-citationRaineri, E., Pan, A., Mondello, P., Acquarolo, A., Candiani, A., & Crema, L. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.06.009 · Cited by 103
Clinical Impact of a Real-Time PCR Assay for Rapid Identification of Staphylococcal Bacteremia
Frye, A. M., Baker, C. A., Rustvold, D. L., Heath, K., Hunt, J., Leggett, J. E., & Oethinger, M. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06169-11 · Cited by 102
“Specifically, a delay in appropriate antibiotic treatment greater than 44 to 48 h after the collection of a blood culture positive for MRSA is associated with increased infection-related mortality and a prolonged length of hospital stay (11, 13).”
BackgroundNickerson, E. K., Hongsuwan, M., Limmathurotsakul, D., Wuthiekanun, V., Shah, K. R., Srisomang, P., Mahavanakul, W., Wacharaprechasgul, T., Fowler, V. G., West, T. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004308 · Cited by 91
“Delays in treating SAB are known to have an adverse effect on outcome [25].”
Background
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.